PremiumThe FlyAmgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints1d agoAZNAMGN
PremiumCompany AnnouncementsAstraZeneca’s Tezspire Hits Key Phase III Goals in Eosinophilic Esophagitis1d agoAZN
PremiumCompany AnnouncementsAstraZeneca Explores Eye Imaging to Spot Hidden Heart Disease: What Investors Should Watch2d agoAZN
PremiumThe FlyAstraZeneca, Daiichi’s TROPION-Urothelial04 phase 3 trial of Datroway initiated2d agoAZN